位置:首页 > 蛋白库 > LST_NEIMB
LST_NEIMB
ID   LST_NEIMB               Reviewed;         371 AA.
AC   P72097; P72099; P72100; P72101;
DT   01-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1997, sequence version 1.
DT   03-AUG-2022, entry version 110.
DE   RecName: Full=N-acetyllactosaminide alpha-2,3-sialyltransferase {ECO:0000305|PubMed:8910446};
DE            EC=2.4.99.6 {ECO:0000269|PubMed:8910446};
DE   AltName: Full=CMP-N-acetylneuraminate:beta-galactoside alpha-2,3-sialyltransferase {ECO:0000303|PubMed:8910446};
DE            Short=CMP-Neu5Ac:beta-galactoside alpha-2,3-sialyltransferase {ECO:0000303|PubMed:8910446};
DE   AltName: Full=Lipooligosaccharide sialyltransferase {ECO:0000303|PubMed:21880735, ECO:0000303|PubMed:8910446};
DE            Short=LOS sialyltransferase {ECO:0000303|PubMed:21880735, ECO:0000303|PubMed:8910446};
GN   Name=lst {ECO:0000303|PubMed:8910446}; OrderedLocusNames=NMB0922;
OS   Neisseria meningitidis serogroup B (strain MC58).
OC   Bacteria; Proteobacteria; Betaproteobacteria; Neisseriales; Neisseriaceae;
OC   Neisseria.
OX   NCBI_TaxID=122586;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, CATALYTIC ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND PATHWAY.
RC   STRAIN=406Y / NRCC 4030, M982B / NRCC 4725, and MC58 / NRCC 4728;
RX   PubMed=8910446; DOI=10.1074/jbc.271.45.28271;
RA   Gilbert M., Watson D.C., Cunningham A.-M., Jennings M.P., Young N.M.,
RA   Wakarchuk W.W.;
RT   "Cloning of the lipooligosaccharide alpha-2,3-sialyltransferase from the
RT   bacterial pathogens Neisseria meningitidis and Neisseria gonorrhoeae.";
RL   J. Biol. Chem. 271:28271-28276(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=126E / NRCC 4010;
RA   Gilbert M., Michniewicz J.J., Watson D.C., Wakarchuk W.W.;
RL   Submitted (DEC-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=MC58;
RX   PubMed=10710307; DOI=10.1126/science.287.5459.1809;
RA   Tettelin H., Saunders N.J., Heidelberg J.F., Jeffries A.C., Nelson K.E.,
RA   Eisen J.A., Ketchum K.A., Hood D.W., Peden J.F., Dodson R.J., Nelson W.C.,
RA   Gwinn M.L., DeBoy R.T., Peterson J.D., Hickey E.K., Haft D.H.,
RA   Salzberg S.L., White O., Fleischmann R.D., Dougherty B.A., Mason T.M.,
RA   Ciecko A., Parksey D.S., Blair E., Cittone H., Clark E.B., Cotton M.D.,
RA   Utterback T.R., Khouri H.M., Qin H., Vamathevan J.J., Gill J., Scarlato V.,
RA   Masignani V., Pizza M., Grandi G., Sun L., Smith H.O., Fraser C.M.,
RA   Moxon E.R., Rappuoli R., Venter J.C.;
RT   "Complete genome sequence of Neisseria meningitidis serogroup B strain
RT   MC58.";
RL   Science 287:1809-1815(2000).
RN   [4]
RP   SUBCELLULAR LOCATION.
RC   STRAIN=MC58;
RX   PubMed=12065517; DOI=10.1128/iai.70.7.3744-3751.2002;
RA   Shell D.M., Chiles L., Judd R.C., Seal S., Rest R.F.;
RT   "The Neisseria lipooligosaccharide-specific alpha-2,3-sialyltransferase is
RT   a surface-exposed outer membrane protein.";
RL   Infect. Immun. 70:3744-3751(2002).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17038831; DOI=10.4161/hv.1.2.1651;
RA   Vipond C., Wheeler J.X., Jones C., Feavers I.M., Suker J.;
RT   "Characterization of the protein content of a meningococcal outer membrane
RT   vesicle vaccine by polyacrylamide gel electrophoresis and mass
RT   spectrometry.";
RL   Hum. Vaccin. 1:80-84(2005).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   STRAIN=NZ98/254 / Serogroup B;
RX   PubMed=16645985; DOI=10.1002/pmic.200500821;
RA   Vipond C., Suker J., Jones C., Tang C., Feavers I.M., Wheeler J.X.;
RT   "Proteomic analysis of a meningococcal outer membrane vesicle vaccine
RT   prepared from the group B strain NZ98/254.";
RL   Proteomics 6:3400-3413(2006).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (1.94 ANGSTROMS) OF 49-370 IN COMPLEXES WITH CMP; CDP
RP   AND THE SUBSTRATE ANALOG CMP-3-FLUORO-N-ACETYL-NEURAMINIC ACID, SUBUNIT,
RP   MUTAGENESIS OF GLU-124; ASP-258; HIS-280 AND ARG-282, REACTION MECHANISM,
RP   AND ACTIVE SITE.
RC   STRAIN=126E / NRCC 4010;
RX   PubMed=21880735; DOI=10.1074/jbc.m111.249920;
RA   Lin L.Y., Rakic B., Chiu C.P., Lameignere E., Wakarchuk W.W., Withers S.G.,
RA   Strynadka N.C.;
RT   "Structure and mechanism of the lipooligosaccharide sialyltransferase from
RT   Neisseria meningitidis.";
RL   J. Biol. Chem. 286:37237-37248(2011).
CC   -!- FUNCTION: Catalyzes the transfer of sialic acid from the substrate CMP-
CC       N-acetylneuraminate to the terminal galactose residue of the lacto-N-
CC       neotetraose branch of surface lipooligosaccharide (LOS), forming an
CC       alpha-2,3-sialyl linkage. Thus, functions in the sialylation of LOS,
CC       which plays a role in the evasion of the host immune response by
CC       protecting N.meningitidis from complement-mediated serum killing and
CC       from phagocytic killing by neutrophils. In vitro, can use a number of
CC       different synthetic acceptors with lactose or galactose as the
CC       saccharide portion, but shows a strong preference for the N-
CC       acetyllactosamine containing acceptor. {ECO:0000269|PubMed:8910446}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl
CC         derivative + CMP-N-acetyl-beta-neuraminate = an N-acetyl-alpha-
CC         neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-
CC         glucosaminyl derivative + CMP + H(+); Xref=Rhea:RHEA:52316,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57812, ChEBI:CHEBI:60377,
CC         ChEBI:CHEBI:133507, ChEBI:CHEBI:136545; EC=2.4.99.6;
CC         Evidence={ECO:0000269|PubMed:8910446};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is 6.0. {ECO:0000269|PubMed:8910446};
CC   -!- PATHWAY: Bacterial outer membrane biogenesis; lipooligosaccharide
CC       biosynthesis. {ECO:0000305|PubMed:8910446}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:21880735}.
CC   -!- SUBCELLULAR LOCATION: Cell outer membrane
CC       {ECO:0000269|PubMed:12065517}; Peripheral membrane protein
CC       {ECO:0000305}; Extracellular side {ECO:0000269|PubMed:12065517}.
CC       Note=Is exclusively found in outer membrane preparations of the
CC       pathogen and is surface exposed. Inner membrane, periplasmic,
CC       cytoplasmic, and culture supernatant fractions are devoid of Lst.
CC       {ECO:0000269|PubMed:12065517}.
CC   -!- MISCELLANEOUS: Present in outer membrane vesicle formulations which are
CC       used as vaccines in human. {ECO:0000269|PubMed:16645985,
CC       ECO:0000269|PubMed:17038831}.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 52 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U60660; AAC44541.1; -; Genomic_DNA.
DR   EMBL; U60661; AAC44543.1; -; Genomic_DNA.
DR   EMBL; U60662; AAC44544.2; -; Genomic_DNA.
DR   EMBL; U60663; AAC44545.1; -; Genomic_DNA.
DR   EMBL; AE002098; AAF41330.1; -; Genomic_DNA.
DR   PIR; D81143; D81143.
DR   RefSeq; NP_273962.1; NC_003112.2.
DR   RefSeq; WP_002244089.1; NC_003112.2.
DR   PDB; 2YK4; X-ray; 1.94 A; A=49-370.
DR   PDB; 2YK5; X-ray; 2.32 A; A=49-370.
DR   PDB; 2YK6; X-ray; 2.83 A; A=49-370.
DR   PDB; 2YK7; X-ray; 2.18 A; A=49-370.
DR   PDBsum; 2YK4; -.
DR   PDBsum; 2YK5; -.
DR   PDBsum; 2YK6; -.
DR   PDBsum; 2YK7; -.
DR   AlphaFoldDB; P72097; -.
DR   SMR; P72097; -.
DR   CAZy; GT52; Glycosyltransferase Family 52.
DR   PaxDb; P72097; -.
DR   EnsemblBacteria; AAF41330; AAF41330; NMB0922.
DR   KEGG; nme:NMB0922; -.
DR   PATRIC; fig|122586.8.peg.1159; -.
DR   HOGENOM; CLU_076077_0_0_4; -.
DR   OMA; CCTPLQV; -.
DR   UniPathway; UPA00501; -.
DR   EvolutionaryTrace; P72097; -.
DR   Proteomes; UP000000425; Chromosome.
DR   GO; GO:0009279; C:cell outer membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0008118; F:N-acetyllactosaminide alpha-2,3-sialyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0009103; P:lipopolysaccharide biosynthetic process; IEA:UniProtKB-KW.
DR   InterPro; IPR012477; Glyco_transf_52.
DR   Pfam; PF07922; Glyco_transf_52; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell outer membrane; Glycosyltransferase;
KW   Lipopolysaccharide biosynthesis; Membrane; Reference proteome; Transferase.
FT   CHAIN           1..371
FT                   /note="N-acetyllactosaminide alpha-2,3-sialyltransferase"
FT                   /id="PRO_0000080574"
FT   ACT_SITE        258
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000305|PubMed:21880735"
FT   ACT_SITE        280
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000305|PubMed:21880735"
FT   BINDING         255
FT                   /ligand="CMP-N-acetyl-beta-neuraminate"
FT                   /ligand_id="ChEBI:CHEBI:57812"
FT                   /evidence="ECO:0000305|PubMed:21880735,
FT                   ECO:0007744|PDB:2YK7"
FT   BINDING         278..282
FT                   /ligand="CMP-N-acetyl-beta-neuraminate"
FT                   /ligand_id="ChEBI:CHEBI:57812"
FT                   /evidence="ECO:0000305|PubMed:21880735,
FT                   ECO:0007744|PDB:2YK7"
FT   BINDING         299..300
FT                   /ligand="CMP-N-acetyl-beta-neuraminate"
FT                   /ligand_id="ChEBI:CHEBI:57812"
FT                   /evidence="ECO:0000305|PubMed:21880735,
FT                   ECO:0007744|PDB:2YK7"
FT   BINDING         322..323
FT                   /ligand="CMP-N-acetyl-beta-neuraminate"
FT                   /ligand_id="ChEBI:CHEBI:57812"
FT                   /evidence="ECO:0000305|PubMed:21880735,
FT                   ECO:0007744|PDB:2YK7"
FT   VARIANT         2
FT                   /note="G -> S (in strain: M982B / NRCC 4725)"
FT   VARIANT         29
FT                   /note="Q -> H (in strain: 406Y / NRCC 4030 and NRCC 4725)"
FT   VARIANT         40
FT                   /note="E -> D (in strain: 406Y / NRCC 4030, M982B / NRCC
FT                   4725 and 126E / NRCC 4010)"
FT   VARIANT         94
FT                   /note="N -> K (in strain: 406Y / NRCC 4030 and M982B / NRCC
FT                   4725)"
FT   VARIANT         102
FT                   /note="R -> W (in strain: 126E / NRCC 4010)"
FT   VARIANT         129
FT                   /note="S -> A (in strain: 126E / NRCC 4010)"
FT   VARIANT         168
FT                   /note="G -> I (in strain: 126E / NRCC 4010)"
FT   VARIANT         242
FT                   /note="T -> A (in strain: 406Y / NRCC 4030 and 126E / NRCC
FT                   4010)"
FT   VARIANT         273
FT                   /note="K -> N (in strain: 406Y / NRCC 4030 and 126E / NRCC
FT                   4010)"
FT   MUTAGEN         124
FT                   /note="E->A: Decreases the binding affinity for the donor
FT                   substrate (but not catalytic rate)."
FT                   /evidence="ECO:0000269|PubMed:21880735"
FT   MUTAGEN         258
FT                   /note="D->N: Loss of catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:21880735"
FT   MUTAGEN         280
FT                   /note="H->A: Decreases the rate of sialic acid transfer."
FT                   /evidence="ECO:0000269|PubMed:21880735"
FT   MUTAGEN         282
FT                   /note="R->A: Decreases both the binding affinity for the
FT                   donor substrate and the rate of sialic acid transfer."
FT                   /evidence="ECO:0000269|PubMed:21880735"
FT   STRAND          50..55
FT                   /evidence="ECO:0007829|PDB:2YK4"
FT   HELIX           58..70
FT                   /evidence="ECO:0007829|PDB:2YK4"
FT   STRAND          74..83
FT                   /evidence="ECO:0007829|PDB:2YK4"
FT   HELIX           87..99
FT                   /evidence="ECO:0007829|PDB:2YK4"
FT   STRAND          100..107
FT                   /evidence="ECO:0007829|PDB:2YK4"
FT   HELIX           122..131
FT                   /evidence="ECO:0007829|PDB:2YK4"
FT   STRAND          136..141
FT                   /evidence="ECO:0007829|PDB:2YK4"
FT   HELIX           144..147
FT                   /evidence="ECO:0007829|PDB:2YK4"
FT   HELIX           149..153
FT                   /evidence="ECO:0007829|PDB:2YK4"
FT   STRAND          158..163
FT                   /evidence="ECO:0007829|PDB:2YK4"
FT   HELIX           167..170
FT                   /evidence="ECO:0007829|PDB:2YK4"
FT   HELIX           173..177
FT                   /evidence="ECO:0007829|PDB:2YK4"
FT   HELIX           179..181
FT                   /evidence="ECO:0007829|PDB:2YK4"
FT   STRAND          183..186
FT                   /evidence="ECO:0007829|PDB:2YK6"
FT   HELIX           187..204
FT                   /evidence="ECO:0007829|PDB:2YK4"
FT   STRAND          210..214
FT                   /evidence="ECO:0007829|PDB:2YK4"
FT   STRAND          224..231
FT                   /evidence="ECO:0007829|PDB:2YK4"
FT   HELIX           237..240
FT                   /evidence="ECO:0007829|PDB:2YK7"
FT   STRAND          249..254
FT                   /evidence="ECO:0007829|PDB:2YK4"
FT   HELIX           259..261
FT                   /evidence="ECO:0007829|PDB:2YK4"
FT   HELIX           262..272
FT                   /evidence="ECO:0007829|PDB:2YK4"
FT   STRAND          276..278
FT                   /evidence="ECO:0007829|PDB:2YK4"
FT   STRAND          290..292
FT                   /evidence="ECO:0007829|PDB:2YK4"
FT   HELIX           299..309
FT                   /evidence="ECO:0007829|PDB:2YK4"
FT   STRAND          314..321
FT                   /evidence="ECO:0007829|PDB:2YK4"
FT   HELIX           324..328
FT                   /evidence="ECO:0007829|PDB:2YK4"
FT   STRAND          334..341
FT                   /evidence="ECO:0007829|PDB:2YK4"
FT   HELIX           346..348
FT                   /evidence="ECO:0007829|PDB:2YK4"
FT   HELIX           351..359
FT                   /evidence="ECO:0007829|PDB:2YK4"
FT   STRAND          364..367
FT                   /evidence="ECO:0007829|PDB:2YK4"
SQ   SEQUENCE   371 AA;  42611 MW;  1C0E51DA3DAACD15 CRC64;
     MGLKKACLTV LCLIVFCFGI FYTFDRVNQG ERNAVSLLKE KLFNEEGEPV NLIFCYTILQ
     MKVAERIMAQ HPGERFYVVL MSENRNEKYD YYFNQIKDKA ERAYFFHLPY GLNKSFNFIP
     TMAELKVKSM LLPKVKRIYL ASLEKVSIAA FLSTYPDAEI KTFDDGTGNL IQSSSYLGDE
     FSVNGTIKRN FARMMIGDWS IAKTRNASDE HYTIFKGLKN IMDDGRRKMT YLPLFDASEL
     KTGDETGGTV RILLGSPDKE MKEISEKAAK NFKIQYVAPH PRQTYGLSGV TTLNSPYVIE
     DYILREIKKN PHTRYEIYTF FSGAALTMKD FPNVHVYALK PASLPEDYWL KPVYALFTQS
     GIPILTFDDK N
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024